Efficacy and Safety of Baricitinib in Patients With Moderate and Severe COVID-19
Clinical trial NCT05056558 · UNKNOWN
Trial details
- NCT number
- NCT05056558
- Sponsor
- Incepta Pharmaceuticals Ltd
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2022-04-01
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.